Facultad de Farmacia
Zentrum
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen de la Victoria (10)
2022
-
Adipose tissue and blood leukocytes ACE2 DNA methylation in obesity and after weight loss
European Journal of Clinical Investigation, Vol. 52, Núm. 2
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
2014
-
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
British Journal of Cancer, Vol. 111, Núm. 8, pp. 1532-1541
2013
2012
-
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: Results from the GEICAM/2006-03, a multicenter, randomized, phase-II study
Annals of Oncology, Vol. 23, Núm. 12, pp. 3069-3074
2010
-
Practical prognostic index for patients with metastatic recurrent breast cancer: Retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register
Breast Cancer Research and Treatment, Vol. 122, Núm. 2, pp. 591-600
2009
-
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735
2008
-
A single-nucleotide polymorphismin the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma
Clinical Cancer Research, Vol. 14, Núm. 3, pp. 811-816
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814
2007
-
Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: A negative outcome study by the Spanish breast cancer research group (GEICAM)
Breast Cancer Research and Treatment, Vol. 101, Núm. 2, pp. 215-223